ÌÇÐÄvlogÃÛÌÒ

Pavan Reddy

Reddy

Pavan Reddy, M.D.

Director

Email

pavan.reddy@bcm.edu

Positions

Director
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄvlogÃÛÌÒ of Medicine
Houston, Texas, United States
Senior Associate Dean, Cancer Programs
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄvlogÃÛÌÒ of Medicine
Houston, Texas, United States
Professor
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄvlogÃÛÌÒ of Medicine
Houston, Texas, United States

Education

MD from Osmania University
Hyderabad, India
Residency at University of Missouri
Columbia, Missouri, United States
Internal Medicine
Fellowship at University of Michigan
Ann Arbor, Michigan, United States
Hematology/Oncology, Bone and Marrow Transplantation

Certifications

Internal Medicine
American Board of Internal Medicine
Medical Oncology
American Board of Internal Medicine

Honors & Awards

Presidential Lecture
City of Hope Cancer Center (01/2022 - 12/2022)
Fellow
American Society of Transplantation and Cell Therapy (01/2022 - 12/2022)
President
American Society of Transplantation and Cell Therapy (01/2020 - 12/2021)
Section Editor
Current Opinion in Hematology (01/2019 - 12/2024)
Section Editor
Frontiers in Immunology (01/2019 - 12/2022)
Deputy Editor
JCI Insight (01/2019 - 12/2024)
President Elect
American Society of Transplantation and Cell Therapy (01/2019 - 12/2020)
Vice-President
American Society of Blood and Marrow Transplantation (01/2018 - 12/2019)
Chair
ASH Awards Review Subcommittee (01/2017 - 12/2021)

Professional Interests

  • Immunobiology of GVHD
  • Development of GVHD

Professional Statement

Dr. Pavan Reddy has a long-standing interest in cellular molecular immunology, metabolism, in vivo animal models, human sample analysis and clinical hematopoietic cell transplantation (HCT) for blood diseases. His lab has contributed to the fundamental understanding of immunology, the biology of graft-versus-host disease, and has successfully translated laboratory observations into proof-of-concept human trials following HCT. His work provided seminal insights into the role of target tissue resilience in mitigating GVHD, the role of non-coding RNAs and intracellular trafficking mechanisms in T cells and led to clinical translation of five distinct and novel approaches in prevention and treatment of GVHD, which are now being studied in randomized national trials. His research has been funded for over a decade with multiple NIH and other peer reviewed grants. As the director of the Dan L Duncan Comprehensive Cancer Center, his major focus has been on promoting access, community engagement, and transdisciplinary research.

Selected Publications

  • 1. Badr H, Rouce R, Scheurer ME, Lulla P, Mims M, Reddy P. " " Cancer Cell. 2023 Dec 11; 41 (12) : 2007-2010.
    Pubmed PMID: .
  • 2. Riwes MM, Golob JL, Magenau J, Shan M, Dick G, Braun T, Schmidt TM, Pawarode A, Anand S, Ghosh M, Maciejewski J, King D, Choi S, Yanik G, Geer M, Hillman E, Lyssiotis CA, Tewari M, Reddy P. " " Nature Medicine. 2023 Nov ; 29 (11) : 2805-2813.
    Pubmed PMID: .
  • 3. Fujiwara H, Seike K, Brooks MD, Mathew AV, Kovalenko I, Pal A, Lee HJ, Peltier D, Kim S, Liu C, Oravecz-Wilson K, Li L, Sun Y, Byun J, Maeda Y, Wicha M, Saunders T, Rehemtulla A, Lyssiotis CA, Pennathur S, Reddy P. " " Nature Immunology. 2021 Nov ; 22 (11) : 1440-1451.
    Pubmed PMID: .
  • Mathewson N, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu SR, Sun Y, Rossi C, Fujiwara H, Byun J, Lindemans C, Calafiore M, Schmidt TC, Honda K, Young VB, Pennathur S, Brink MVD, Reddy P. " " Nature Immunology. 2016 May ; 17 (5) : 505-13.
    Pubmed PMID: .

to edit your profile